Martha Morrell, Chief Medical Officer at NeuroPace Inc (NPCE), sold 828 shares at $15.03 ($12K) on 2024-01-24, disclosed to the SEC on 2024-01-26.
Scheduled sale ($12k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.03 | 827 | $12K | 99.9% |
| 2 | $15.00 | 1 | $15 | 0.1% |
| Total | $15.03 avg | 828 | $12K | 100% |
| Filing → |
| NPCE | SELL | 2025-01-31 | $5K | — | Filing → |
| NPCE | SELL | 2025-01-28 | $48K | — | Filing → |
| NPCE | SELL | 2024-02-06 | $531K | — | Filing → |